Kiehlbauch J A, Baker C N, Wachsmuth I K
Enteric Diseases Branch, Centers for Disease Control, Atlanta, Georgia 30333.
Antimicrob Agents Chemother. 1992 Apr;36(4):717-22. doi: 10.1128/AAC.36.4.717.
We evaluated the in vitro activities of 22 antimicrobial agents against 78 human and animal isolates belonging to two aerotolerant Campylobacter species, C. cryaerophila and C. butzleri, using a broth microdilution technique. An additional 10 antimicrobial agents were included at concentrations found in selective Campylobacter media. Strains of C. cryaerophila belonged to two DNA hybridization groups: DNA hybridization group 1A, which includes the type strain of C. cryaerophila, and DNA hybridization group 1B. The aminoglycosides, fluoroquinolones, and one tetracycline (minocycline) demonstrated the most activity against all DNA hybridization groups (C. cryaerophila DNA groups 1A and 1B and C. butzleri). Most isolates were resistant to cephalosporin antibiotics, with the exception of cefotaxime, and were variably susceptible to trimethoprim-sulfamethoxazole. C. cryaerophila DNA hybridization group 1A isolates were generally susceptible to the tetracyclines, chloramphenicol, nalidixic acid, azithromycin, erythromycin, and roxithromycin and moderately susceptible to clindamycin, trimethoprim-sulfamethoxazole, ampicillin, and ampicillin-sulbactam. The MICs of tetracyclines were higher for C. butzleri and C. cryaerophila DNA hybridization group 1B isolates than for C. cryaerophila DNA hybridization group 1A isolates, but most strains were still susceptible to doxycycline and tetracycline; all isolates were susceptible to minocycline. C. butzleri and C. cryaerophila DNA hybridization group 1B isolates were generally resistant to the macrolide antibiotics (including erythromycin), chloramphenicol, clindamycin, nalidixic acid, ampicillin, and trimethoprim-sulfamethoxazole. Differences in antimicrobial susceptibility between aerotolerant Campylobacter species and more common Campylobacter species, e.g., C. jejuni, suggest that different treatment strategies may be necessary. Strains of all three DNA hybridization groups of aerotolerant Campylobacter isolates were susceptible to colistin, polymyxin B, and rifampin at concentrations commonly used in selective media. These results suggest that primary isolation methods for Campylobacter species may need to be modified to include aerotolerant Campylobacter strains.
我们采用肉汤微量稀释技术,评估了22种抗菌剂对78株属于两种耐氧弯曲杆菌物种(嗜低温弯曲杆菌和布氏弯曲杆菌)的人类和动物分离株的体外活性。另外10种抗菌剂以在选择性弯曲杆菌培养基中发现的浓度加入。嗜低温弯曲杆菌菌株属于两个DNA杂交组:DNA杂交组1A(包括嗜低温弯曲杆菌的模式菌株)和DNA杂交组1B。氨基糖苷类、氟喹诺酮类和一种四环素(米诺环素)对所有DNA杂交组(嗜低温弯曲杆菌DNA组1A和1B以及布氏弯曲杆菌)表现出最强的活性。除头孢噻肟外,大多数分离株对头孢菌素类抗生素耐药,对甲氧苄啶 - 磺胺甲恶唑的敏感性各不相同。嗜低温弯曲杆菌DNA杂交组1A分离株通常对四环素类、氯霉素、萘啶酸、阿奇霉素、红霉素和罗红霉素敏感,对克林霉素、甲氧苄啶 - 磺胺甲恶唑、氨苄西林和氨苄西林 - 舒巴坦中度敏感。布氏弯曲杆菌和嗜低温弯曲杆菌DNA杂交组1B分离株的四环素类药物最低抑菌浓度高于嗜低温弯曲杆菌DNA杂交组1A分离株,但大多数菌株对多西环素和四环素仍敏感;所有分离株对米诺环素敏感。布氏弯曲杆菌和嗜低温弯曲杆菌DNA杂交组1B分离株通常对大环内酯类抗生素(包括红霉素)、氯霉素、克林霉素、萘啶酸、氨苄西林和甲氧苄啶 - 磺胺甲恶唑耐药。耐氧弯曲杆菌物种与更常见的弯曲杆菌物种(如空肠弯曲杆菌)之间抗菌敏感性的差异表明可能需要不同的治疗策略。耐氧弯曲杆菌分离株的所有三个DNA杂交组的菌株在选择性培养基常用浓度下对黏菌素、多黏菌素B和利福平敏感。这些结果表明,弯曲杆菌物种的初次分离方法可能需要修改,以纳入耐氧弯曲杆菌菌株。